DOI QR코드

DOI QR Code

CsA Affects the Rat Submandibular Glands via Regulating the CypA Expression

  • Lee, Eun-Joo (Dental Science Research Institute, School of Dentistry, Chonnam National University) ;
  • Hong, Young-Gil (Dental Science Research Institute, School of Dentistry, Chonnam National University) ;
  • Yoo, Hong-Il (Dental Science Research Institute, School of Dentistry, Chonnam National University) ;
  • Yang, So-Young (Dental Science Research Institute, School of Dentistry, Chonnam National University) ;
  • Kang, Jee-Hae (Dental Science Research Institute, School of Dentistry, Chonnam National University) ;
  • Kim, Min-Seok (Dental Science Research Institute, School of Dentistry, Chonnam National University) ;
  • Kim, Sun-Hun (Dental Science Research Institute, School of Dentistry, Chonnam National University)
  • 투고 : 2012.08.31
  • 심사 : 2012.12.10
  • 발행 : 2012.12.31

초록

The effects of the an immunosuppressive drug cyclosporine A (CsA), on the salivary gland are largely unknown, even though clinical trials for the stimulation of salivation using CsA have been attempted. Cyclophilin A (CypA) is known to be a binding protein for CsA. CypA has cell proliferation and tissue matrix change activities. In our present study, the presence of CypA in the gland and effects of CsA on CypA expression were investigated by immunohistochemistry, immunoblotting and RT-PCR analyses. CypA was immunohistochemically detected in various kinds of ducts in the submandibular glands of Sprague Dawley rats. The CypA mRNA level was highest at postnatal day 1 and gradually decreased in a time-dependent manner up to adulthood. The expression of CypA increased after a 10 day subcutaneous administration of CsA in postnatal day 1 rats. Surgical sections of the chorda-lingual nerve with impaired salivation showed no changes in CypA expression. A cell proliferation assay using PCNA anti-serum showed increased cell division following CsA treatment. These results suggest that CsA and CypA may act on ductal cells to regulate saliva composition rather than salivation levels.

키워드

참고문헌

  1. Laupacis A, Keown PA, Ulan RA, McKenzie N, Stiller CR. Cyclosporine A: a powerful immunosuppressant. Can Med Assoc J. 1982;126:1041-1046.
  2. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin- cyclosporine A and FKBP‐FK506 complexes. Cell. 1991;66:807-815.
  3. Parsons JN, Wiederrecht GJ, Salowe S, Burbaum JJ, Rokosz LL, Kincaid RL, O'Keefe SJ. Regulation of calcineurin phosphatase activity and interaction with the FK506-FKBP12 binding protein complex. J Biol Chem. 1994;269:19610-19616.
  4. Sigal NH, Dumont FJ. Cyclosporine A. FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol. 1992;10:519-560.
  5. Koprak S, Sirotina A, Ok H, Dumont FJ. Depletion of the mature $CD_{4}\;^{+}$ $8^{-}$ thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. Transplantation. 1996;61:926-932.
  6. Ge X, Yu G, Cai Z, Mao C. Long term survival of an allografted submandibular gland in a miniature swine model given immunosuppressant drugs. Bri J Oral Maxillofac Surg. 2006;44:146-151.
  7. Jung JY, Seol K, Jeong YJ, Kim WJ, Oh SJ. Proteomic Analysis of Rat PC12 Cells Exposed to Cyclosporin A. Int J Oral Biol. 2009;34(1);29-36.
  8. Galat A. Peptidylproline cis-trans-isomerases: immunophilins. Eur J Biochem. 1993;216:689-707.
  9. Kofron JL, Kuzmic P, Kishore V, Colon-Bonilla E, Rich DH. Determination of kinetic constants for peptidyl prolyl cistrans isomerases by an improved spectrophotometric assay. Biochemistry. 1991;30:6127-6134.
  10. Fruman DA, Burakoff SJ, Bierer BE. Immunophilins in protein folding and immunosuppression. FASEB J. 1994;8: 391-400.
  11. Liu J. FK506 and cyclosporine, molecular probes for studying intracellular signal transduction. Trends in immunol. 1993;14:290-295.
  12. Sherry B, Yarlett N, Strupp A, Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages. Proc Natl Acad Sci USA. 1992;89:3511-3515.
  13. Xu Q, Leiva MC, Fischkoff SA, Handschumacher RE, Lyttle CR. Leukocyte chemotactic activity of cyclophilin. J Biol Chem. 1992;267:11968-11971.
  14. Jin ZG, Melaragno MG, Liao DF, Yan C, Haendeler J, Suh YA, Lambeth JD, Berk BC. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res. 2000; 87:789-796.
  15. Kasinrerk W, Tokrasinwit N, Phunpae P. CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-1/ICAM-1 pathway. Immunology. 1999;96:184-192.
  16. Allain F, Vanpouille C, Carpentier M, Slomianny, MC, Durieux S, Spik G. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin‐mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc Natl Acad Sci USA. 2002;99:2714-2719.
  17. Seko Y, Fujimura T, Taka H, Mineki R, Murayama K, Nagai R. Hypoxia followed by reoxygenation induces secretin of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun. 2004;317:162‐168.
  18. Park JI, Lee GS, Jeong YJ, Kim BK, Kim JH, Lim HS, Kim SH, Kim WJ, Jung JY. Involvement of Antiapoptotic Signals in Rat PC12 Cells Proliferation by Cyclosporin A Treatment. Int J Oral Biol. 2007;32(2):51-7.
  19. Kim SH, Lessner SM, Sakurai Y, Galis ZS. Cyclophilin A as a novel mediator of endothelial activation and dysfunction. Am J Pathol. 2004;164:1567-1574.
  20. Denny PC, Ball WD, Redman RS. Salivary glands: a paradigm for diversity of gland development. Crit Rev Oral Biol Med. 1997;8:51-75.
  21. Chang JC. Canalicular blockage. Aust J Ophthamol. 1973; 1:58-62.
  22. Dardenne M, Savino W, Feutren G, Bach JF. Stimulatory effects of cyclosporine A on human and mouse thymic epithelial cells. Eur J Immunol. 1987;17:275-279.
  23. Dehpour AR, Nouhnejad P, Mousavizadeh K, Ghfourifar P, Djamali M, Borhanimoghdam B. Cyclosporine A‐induced functional and morphological changes in pilocarpine treated rat submandibular glands. Toxicology. 1996;108: 65-71.
  24. Yoshida A, Fujihara T, Nakata K. Cyclosporine A increases tear fluid secretion via release of sensory neurotransmitters and muscarinic pathways in mice. Exp Eye Res. 1999;68:541-546.
  25. Giglio JM, Vatta MS, Bianciotti LG, Lomniczi A, Elverdin JC. Cyclosporine A: effects on the secretory process and noradrenergic activity in the submandibular gland of the rat. Neuroimmunomodulation. 2001;9:170-176.
  26. Tsubota K, Saito I, Ishimaru N, Hayashi Y. Use of topical cyclosporine A in a primary Sjogren's syndrome mouse model. Invest Ophthalmol Vis Sci. 1998;39:1551-1559.
  27. Thanou-Stavraki A, James JA. Primary Sjogren's syndrome: current and prospective therapies. Semin Arthritis Rheum. 2008;37(5):273-292. .
  28. Gresik EW, Barka T. Precocious development of granular convoluted tubules in the mouse submandibular gland induced by thyroxine or by thyroxine and testosterone. Am J Anat. 1980;159:177-185.
  29. Gresik EW, Schenkein I, van der Noen H, Barka T. Hormonal regulation of epidermal growth factor and protease in the submandibular gland of the adult mouse. Endocrinology. 1981;109:924-929.
  30. Jacoby F, Leeson CR. The postnatal development of the rat submaxillary gland. J Anat. 1959;93:201-216.
  31. Woods AL, Hall PA, Shepherd NA, Hanby AM, Waseem NH, Lane DP, Levison DA. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology. 1991;19: 21-27.